UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)
ContributorsBar, Jair; Peled, Nir; Schokrpur, Shiruyeh; Wolner, Mirjana; Rotem, Ofer; Girard, Nicolas; Aboubakar Nana, Frank; Derijcke, Sofie; Kian, Waleed; Patel, Sandip; Gantz-Sorotsky, Hadas; Zer, Alona; Moskovitz, Mor; Metro, Giulio; Rottenberg, Yakir; Calles, Antonio; Hochmair, Maximilian; Cuppens, Kristof; Decoster, Lynn; Reck, Martin; Limon, Dror; Rodriguez, Estelamari; Astaras, Christoforos; Bettini, Adrienne; Häfliger, Simon; Addeo, Alfredo
Published inJournal of thoracic oncology, vol. 18, no. 2, p. 169-180; 169-180
Publication date2023-02
First online date2022-10-25
Abstract
Keywords
- Compound mutations
- Metastatic
- NSCLC
- Uncommon EGFR mutation
- Female
- Humans
- Middle Aged
- Male
- Lung Neoplasms / drug therapy
- Lung Neoplasms / genetics
- ErbB Receptors / genetics
- Retrospective Studies
- Mutation
- Protein Kinase Inhibitors / pharmacology
- Protein Kinase Inhibitors / therapeutic use
- Aniline Compounds / pharmacology
- Aniline Compounds / therapeutic use
- Brain Neoplasms / drug therapy
- Brain Neoplasms / genetics
Affiliation
Citation (ISO format)
BAR, Jair et al. UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN). In: Journal of thoracic oncology, 2023, vol. 18, n° 2, p. 169–180. doi: 10.1016/j.jtho.2022.10.004
Main files (1)
Article (Published version)
Identifiers
- PID : unige:171933
- DOI : 10.1016/j.jtho.2022.10.004
- PMID : 36307041
ISSN of the journal1556-0864